2023
DOI: 10.4097/kja.22579
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous versus perineural dexmedetomidine as adjuvant in adductor canal block for total knee arthroplasty

Abstract: This article has been accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination, and proofreading processes, which may lead to differences between this version and the version of record.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
(44 reference statements)
0
0
0
Order By: Relevance
“…It was previously summarized in our review. 43 (1) Peripheral level: perineural dexmedetomidine can maintain the hyperpolarized state of cells by inhibiting the activation of I h current (a non-inactivating, inwardly rectifying current carried by both Na + and K + ions, which is also called the pacemaker current because it is believed to play a significant role in cell excitability) and activates α 2 -adrenoceptor in peripheral blood vessels, constricting blood vessels around the injection site; 20,44 (2) Spinal cord level: dexmedetomidine inhibits the release of excitatory neurotransmitters such as glutamate and substance P in the spinal; 45 (3) Supraspinal level: dexmedetomidine may have a certain amount of systemic absorption and inhibit the descending noradrenergic pathway in the medulla or reduce sympathetic nerve signals, thereby partly achieving its analgesic effect from the central level. 46 Due to this systemic absorption, perineural dexmedetomidine may have similar effects as IV administration.…”
Section: Discussionmentioning
confidence: 99%
“…It was previously summarized in our review. 43 (1) Peripheral level: perineural dexmedetomidine can maintain the hyperpolarized state of cells by inhibiting the activation of I h current (a non-inactivating, inwardly rectifying current carried by both Na + and K + ions, which is also called the pacemaker current because it is believed to play a significant role in cell excitability) and activates α 2 -adrenoceptor in peripheral blood vessels, constricting blood vessels around the injection site; 20,44 (2) Spinal cord level: dexmedetomidine inhibits the release of excitatory neurotransmitters such as glutamate and substance P in the spinal; 45 (3) Supraspinal level: dexmedetomidine may have a certain amount of systemic absorption and inhibit the descending noradrenergic pathway in the medulla or reduce sympathetic nerve signals, thereby partly achieving its analgesic effect from the central level. 46 Due to this systemic absorption, perineural dexmedetomidine may have similar effects as IV administration.…”
Section: Discussionmentioning
confidence: 99%